The association between naturalistic use of psychedelics and co-occurring substance use disorders
Frontiers in Psychiatry January 10, 2023 Jonina Rabinowitz, Raz Gross, Shaul Lev-Ran 15 citations
Objective Classic psychedelics (LSD, psilocybin, and peyote/mescaline) have been used to support addiction treatment in a variety of contexts ranging from ceremonial use to clinical trials. The aim of this study was to test the hypothesis that past naturalistic use of classic psychedelics would be associated with decreased prevalence of substance use disorder, when controlling for known...